Abstract
For the first time we present data showing that metabolic targeted therapy with dichloroacetate (DCA) may improve the outcome of photodynamic therapy. This treatment modality can be easily introduced into clinical practice guidelines.
Abbreviations
- PpIX:
-
Protoporphyrin IX
- PDT:
-
Photodynamic therapy
- PS:
-
Photosensitizer
References
M. Kwitniewski, A. Juzeniene, R. Glosnicka and J. Moan, Immunotherapy: a way to improve the therapeutic outcome of photo-dynamic therapy?, Photochem. Photobiol. Sci., 2008, 7, 1011–1017.
M. Kwitniewski, D. Jankowski, K. Jaskiewicz, H. Dziadziuszko, A. Juzeniene, J. Moan, L. W. Ma, R. Peksa, D. Kunikowska, A. Graczyk, M. Kwasny, M. Kaliszewski and R. Glosnicka, Photody-namic therapy with 5-aminolevulinic acid and diamino acid derivatives of protoporphyrin IX reduces papillomas in mice without eliminating transformation into squamous cell carcinoma of the skin, Int. J. Cancer, 2009, 125, 1721–1727.
R. H. Xu, H. Pelicano, Y. Zhou, J. S. Carew, L. Feng, K. N. Bhalla, M. J. Keating and P. Huang, Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia, Cancer Res., 2005, 65, 613–621.
C. Ruckenstuhl, S. Buttner, D. Carmona-Gutierrez, T. Eisenberg, G. Kroemer, S. J. Sigrist, K. U. Frohlich and F. Madeo, The Warburg effect suppresses oxidative stress induced apoptosis in a yeast model for cancer, PLoS One, 2009, 4, e4592.
E. D. Michelakis, L. Webster and J. R. Mackey, Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer, Br. J. Cancer, 2008, 99, 989–994.
P. W. Stacpoole, L. R. Gilbert, R. E. Neiberger, P. R. Carney, E. Valenstein, D. W. Theriaque and J. J. Shuster, Evaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate, Pediatrics, 2008, 121, e1223–8.
E. Hassoun, C. Kariya and F. E. Williams, Dichloroacetate-induced developmental toxicity and production of reactive oxygen species in zebrafish embryos, J. Biochem. Mol. Toxicol., 2005, 19, 52–58.
S. Bonnet, S. L. Archer, J. Allalunis-Turner, A. Haromy, C. Beaulieu, R. Thompson, C. T. Lee, G. D. Lopaschuk, L. Puttagunta, S. Bonnet, G. Harry, K. Hashimoto, C. J. Porter, M. A. Andrade, B. Thebaud and E. D. Michelakis, A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth, Cancer Cell, 2007, 11, 37–51.
R. A. Cairns, I. Papandreou, P. D. Sutphin and N. C. Denko, Metabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapy, Proc. Natl. Acad. Sci. U. S. A., 2007, 104, 9445–9450.
N. C. Denko, Hypoxia, HIF1 and glucose metabolism in the solid tumour, Nat. Rev. Cancer, 2008, 8, 705–713.
D. Nowis, M. Makowski, T. Stoklosa, M. Legat, T. Issat and J. Golab, Direct tumor damage mechanisms of photodynamic therapy, Acta Biochim. Pol., 2005, 52, 339–352.
A. P. Castano, T. N. Demidova and M. R. Hamblin, Mechanisms in photodynamic therapy: Part three - Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction, Photodiagn. Photodyn. Ther., 2005, 2, 91–106.
P. Steinbach, H. Weingandt, R. Baumgartner, M. Kriegmair, F. Hofstadter and R. Knuchel, Cellular fluorescence of the endogenous photosensitizer protoporphyrin IX following exposure to 5-aminolevulinic acid, Photochem. Photobiol., 2008, 62, 887–895.
N. Schoenfeld, R. Mamet, Y. Nordenberg, M. Shafran, T. Babushkin and Z. Malik, Protoporphyrin biosynthesis in melanoma B16 cells stimulated by 5-aminolevulinic acid and chemical inducers: characterization of photodynamic inactivation, Int. J. Cancer, 2007, 56, 106–112.
J. Hanania and Z. Malik, The effect of EDTA and serum on endogenous porphyrin accumulation and photodynamic sensitization of human K562 leukemic cells, Cancer Lett., 1992, 65, 127–131.
S. Iinuma, S. S. Farshi, B. Ortel and T. Hasan, A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin, Br. J. Cancer, 1994, 70, 21–28.
R. C. Sun, M. Fadia, J. E. Dahlstrom, C. R. Parish, P. G. Board and A. C. Blackburn, Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo, Breast Cancer Res. Treat., 2010, 120, 253–260.
S. Dhar and S. J. Lippard, Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate, Proc. Natl. Acad. Sci. U. S. A., 2009, 106, 22199–22204.
W. Cao, S. Yacoub, K. T. Shiverick, K. Namiki, Y. Sakai, S. Porvasnik, C. Urbanek and C. J. Rosser, Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation, Prostate, 2008, 68, 1223–1231.
J. Y. Wong, G. S. Huggins, M. Debidda, N. C. Munshi and I. De Vivo, Dichloroacetate induces apoptosis in endometrial cancer cells, Gynecol. Oncol., 2008, 109, 394–402.
P. Kaufmann, K. Engelstad, Y. Wei, S. Jhung, M. C. Sano, D. C. Shungu, W. S. Millar, X. Hong, C. L. Gooch, X. Mao, J. M. Pascual, M. Hirano, P. W. Stacpoole, S. DiMauro and D. C. De Vivo, Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial, Neurology, 2006, 66, 324–330.
P. W. Stacpoole, D. S. Kerr, C. Barnes, S. T. Bunch, P. R. Carney, E. M. Fennell, N. M. Felitsyn, R. L. Gilmore, M. Greer, G. N. Henderson, A. D. Hutson, R. E. Neiberger, R. G. O’Brien, L. A. Perkins, R. G. Quisling, A. L. Shroads, J. J. Shuster, J. H. Silverstein, D. W. Theriaque and E. Valenstein, Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children, Pediatrics, 2006, 117, 1519–1531.
D. Newby, L. Marks and F. Lyall, Dissolved oxygen concentration in culture medium: assumptions and pitfalls, Placenta, 2005, 26, 353–357.
K. M. Anderson, J. Jajeh, P. Guinan and M. Rubenstein, In vitro effects of dichloroacetate and CO2 on hypoxic HeLa cells, Anticancer Res., 2009, 29, 4579–4588.
S. Shahrzad, K. Lacombe, U. Adamcic, K. Minhas and B. L. Coomber, Sodium dichloroacetate (DCA) reduces apoptosis in colorectal tumor hypoxia, Cancer Lett., 2010.
E. D. Michelakis, G. Sutendra, P. Dromparis, L. Webster, A. Haromy, E. Niven, C. Maguire, T. L. Gammer, J. R. Mackey, D. Fulton, B. Abdulkarim, M. S. McMurtry and K. C. Petruk, Metabolic modulation of glioblastoma with dichloroacetate, Sci. Transl. Med., 2010, 2, 31ra34.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kwitniewski, M., Moan, J. & Juzeniene, A. Metabolic-targeted therapy with dichloroacetate (DCA): a novel treatment strategy to improve the outcome of photodynamic therapy. Photochem Photobiol Sci 10, 25–28 (2011). https://doi.org/10.1039/c0pp00193g
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1039/c0pp00193g